PuriCore and ECT Sign Acquisition Agreement for ECT’s Intellectual Property Assets

MALVERN, Pa. & STAFFORD, U.K. & ST. LOUIS--(BUSINESS WIRE)--PuriCore (LSE: PURI), the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, and Electro-Chemical Technologies Ltd. (Pink Sheets: ELCH) (ECT) today announced the signing of an agreement for PuriCore to acquire ECT’s intellectual property portfolio. The acquisition includes nine issued U.S. patents related to electrolyzed water equipment and processes. Additionally, PuriCore has signed separate agreements to hire two senior ECT scientists who bring many years of collective experience in electrolyzed water technology. The deal will enable PuriCore to expand its operations in commercial and industrial water treatment.

MORE ON THIS TOPIC